The content streaming market is heating up with Disney’s announcement of Disney+, and the company plans to price it competitively too.
Mustang Bio was the big headline of the stock market in April’s third week, on the back of a successful gene therapy treatment.
Amazon’s ad revenue is rising significantly as a result of consumers preferring it over Google for product searches, and advertisers see value in it.
Reebonz and Anadarko made the headlines this week with their gains, along with SPI Energy and Walt Disney. Era, ATA and X4 weren’t so fortunate.
Not all dividend stocks are worth acquiring. There are some that are really promising, and one of these is a gaming stock as well.
Rumbleon, Cel-Sci and Golden Bull were among the greatest gainers in the first week of April, while Verb Technology and Livanova struggled.
If you’re looking for IoT stocks, you could get confused. Instead, look for stocks representing companies whose business is directly influenced by IoT.
Euro Tech, Tricida and China Internet Financial had the greatest gains. Reebonz had the most dramatic week, eventually losing.
The acquisition of 21st Century Fox gives Disney an enviable list of content titles. But these could also translate to ideas for theme parks.
SPI Energy, Phunware & Sorrento Therapeutics are among the massive gainers this week, while it was gloom for pharma companies Conatus, Biogen and Chiasma.